Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALCAR and ALA for Bipolar Depression
NCT00719706Phase 2Completed
- Sponsor
- McLean Hospital
- Start
- Aug 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetyl-l-carnitine, alpha-lipoic acid in bipolar disorder (BD), sponsored by McLean Hospital. Started Aug 2008; status: completed.
02
Drugs
acetyl-l-carnitinealpha-lipoic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00719706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719706.